COUGHLIN TIMOTHY 4
4 · Travere Therapeutics, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
Coughlin Timothy P
Director
Transactions
- Award
Common Stock
2023-05-17+4,500→ 42,500 total - Award
Stock option (right to buy)
2023-05-17+13,500→ 13,500 totalExercise: $17.11From: 2024-05-17Exp: 2033-05-16→ Common Stock (13,500 underlying)
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.